COCP Logo

Cocrystal Pharma, Inc. (COCP) 

NASDAQ$1.56
Market Cap
$15.87M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
529 of 922
Rank in Industry
311 of 526

COCP Insider Trading Activity

COCP Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials â€¦

Insider Activity of Cocrystal Pharma, Inc.

Over the last 12 months, insiders at Cocrystal Pharma, Inc. have bought $0 and sold $0 worth of Cocrystal Pharma, Inc. stock.

On average, over the past 5 years, insiders at Cocrystal Pharma, Inc. have bought $1.02M and sold $1.7M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,015,229 shares for transaction amount of $2M was made by FROST PHILLIP MD ET AL () on 2023‑04‑04.

List of Insider Buy and Sell Transactions, Cocrystal Pharma, Inc.

2023-04-04PurchaseFROST PHILLIP MD ET AL
1.02M
11.981%
$1.97$2M-5.85%
2021-08-20PurchasePFENNIGER RICHARD C JRdirector
40,000
0.0414%
$1.03$41,120-46.08%
2021-05-04SaleSchinazi Raymond F10 percent owner
575,000
0.9104%
$2.95$1.7M-56.54%
2019-10-25PurchaseSchinazi Raymond F10 percent owner
7,906
0.0202%
$1.15$9,092-14.81%
2019-10-24PurchaseSchinazi Raymond F10 percent owner
5,094
0.0122%
$1.15$5,858-20.00%
2019-10-23PurchaseSchinazi Raymond F10 percent owner
3,935
0.0085%
$1.04$4,087-20.00%
2016-12-23SaleLee Sam
2.2M
0.343%
$0.44$968,000-37.50%
2016-09-01PurchaseWILCOX GARY
10,000
0.0015%
$0.41$4,100-30.00%
2016-09-01PurchaseSchinazi Raymond F
4.88M
0.7103%
$0.41$2M-30.00%
2016-09-01PurchaseBLOCK DAVID S
10,000
0.0015%
$0.41$4,100-30.00%
2016-03-15PurchaseSchinazi Raymond F
2.94M
0.3532%
$0.51$1.5M-22.95%
2016-03-15PurchaseFROST PHILLIP MD ET AL
2.94M
0.3532%
$0.51$1.5M-22.95%
2016-03-15PurchaseWILCOX GARY
49,020
0.0059%
$0.51$25,000-22.95%
2016-03-15PurchaseHSIAO JANE PH D
1.24M
0.1484%
$0.51$630,000-22.95%
2016-03-15PurchaseRubin Steven D
39,216
0.0047%
$0.51$20,000-22.95%
2016-03-15PurchaseMeckler Jeffrey A
294,118
0.0353%
$0.51$150,000-22.95%
2016-03-15PurchaseBLOCK DAVID S
50,000
0.006%
$0.51$25,500-22.95%
2015-12-23PurchaseMeckler Jeffrey A
100,000
0.0151%
$0.58$57,870-3.64%
2015-04-21PurchaseSchinazi Raymond F
3.46M
0.4605%
$0.92$3.19M-26.00%
2015-03-25PurchaseFROST PHILLIP MD ET AL
3.46M
0.4593%
$0.92$3.19M-22.77%
Total: 29

Insider Historical Profitability

<0.0001%
WILCOX GARY
16948605
166.5907%
$26.44M30
Schinazi Raymond F10 percent owner
7674960
75.4385%
$11.97M61<0.0001%
HSIAO JANE PH D
3435294
33.7661%
$5.36M20
FROST PHILLIP MD ET AL
1319838
12.9729%
$2.06M60<0.0001%
Rubin Steven D
733484
7.2095%
$1.14M20

Historical Insider Profitability vs. Competitors

$296,936
37
-18.12%
$13.91M
$85,897,100
36
2.47%
$17.42M
$217,684
34
1.61%
$14.48M
$383,884
32
-25.10%
$13.89M
$4,368,362
28
-22.35%
$17M

COCP Institutional Investors: Active Positions

Increased Positions9+42.86%24,098+3.35%
Decreased Positions5-23.81%31,967-4.44%
New Positions5New10,279New
Sold Out Positions0Sold Out0Sold Out
Total Postitions25+19.05%711,457-1.09%

COCP Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$453.002.76%275,65600%2024-12-31
Renaissance Technologies Llc$207.001.26%125,828-4,200-3.23%2024-12-31
Blackrock, Inc.$121.000.74%73,74600%2024-12-31
Geode Capital Management, Llc$113.000.69%68,890+2,630+3.97%2024-12-31
Morgan Stanley$106.000.64%64,346+5,046+8.51%2024-12-31
State Street Corp$34.000.21%20,54300%2024-12-31
Parallel Advisors, Llc$25.000.15%15,22800%2024-12-31
Dimensional Fund Advisors Lp$25.000.15%15,015+923+6.55%2024-12-31
Northern Trust Corp$20.000.12%12,17100%2024-12-31
Susquehanna International Group, Llp$20.000.12%12,127-25,673-67.92%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.